What to know about Dr. Heidi Overton, Trump’s pick to lead the FDA
PBS News Hour – Politics — 2026-08-19 17:40:00 — www.pbs.org
President Trump Nominates Health Policy Aide to Lead FDA Amid Controversy Over Vaccine Policy
President Trump has nominated Dr. Heidi Overton, a top White House health policy aide, to head the Food and Drug Administration (FDA). Overton is a strong supporter of the president’s health agenda, including efforts to overhaul the childhood vaccine schedule and to separate the measles, mumps, and rubella (MMR) vaccine into individual shots. These proposed changes have drawn sharp criticism from medical experts, who warn that such moves depart from established scientific consensus and could undermine public health.
Challenging Vaccine Consensus
Dr. Overton’s support for a “more slimmed-down and spaced-out version” of the current childhood vaccine schedule aligns with President Trump’s executive order on the issue. This approach is not widely supported among FDA experts or the broader medical community, who emphasize that the current vaccine schedule is based on decades of research and is critical to preventing outbreaks of dangerous diseases. The effort to separate the MMR vaccine into individual shots, in particular, has been criticized for lacking scientific justification and for potentially increasing the risk of disease outbreaks.
FDA Leadership at a Critical Moment
Overton’s nomination comes as the FDA faces significant challenges. The agency has lost more than 3,000 employees due to administration cuts, raising concerns about its ability to carry out essential functions such as food and drug inspections and the review of new medical products. Food safety is also a growing concern, with recent data showing about 10,500 cases of foodborne illness outbreaks this year—seven times higher than the annual average in recent years.
Overton’s background as a physician and public health expert is notable, but she is primarily known for her political work as a top policy aide to President Trump. Her close relationship with the president and her involvement in shaping controversial health policies are likely to be key topics during her Senate confirmation process.
Conclusion
President Trump’s decision to nominate Dr. Heidi Overton to lead the FDA signals a continued push to reshape longstanding vaccine policy, despite strong opposition from medical experts. As the FDA grapples with staffing shortages and rising public health challenges, Overton’s nomination highlights the administration’s willingness to challenge scientific consensus in pursuit of its health agenda. The outcome of her confirmation process will have significant implications for the future direction of the FDA and the nation’s public health policies.
Source: https://www.pbs.org/newshour/show/what-to-know-about-dr-heidi-overton-trumps-pick-to-lead-the-fda